CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neutral
AI Analysis

Summary

Nektar Therapeutics announced the grant of non-qualified stock options to purchase 25,200 shares of common stock under Nasdaq inducement grant rules on August 20, 2026.

Importance:1/10
Sentiment:
0.00
stock grantscompensationinducement grantsnasdaq rule 5635
Related Companies

Read the original article

Published by PR Newswire Pharma on August 28, 2026 8:15 PM

Read Original